Reversible posterior leukoencephalopathy syndrome after treatment of diffuse large B-cell lymphoma

Onkologie

Volumn 30, Issue 3, 2007, Pages 138-140

  Haefner, M D ^a   Siciliano, R D ^a   Widmer, L A ^a   Vogel Wigger, B M ^b   Frick, S ^c  

^a Stadtspital Triemli   (Switzerland)

^b Neurologie   (Switzerland)

^c Medizinische Klinik Zurich   (Switzerland)

Author keywords

B cell lymphoma, diffuse large; Chemotherapy; Leukoencephalopathy syndrome, reversible posterior; Rituximab

Indexed keywords

ACICLOVIR; ANTICONVULSIVE AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; ARTICLE; AUTOREGULATION; B CELL LYMPHOMA; BLOOD FLOW; BLOOD PRESSURE REGULATION; BRAIN CORTEX; BRAIN REGION; CANCER CHEMOTHERAPY; CASE REPORT; COMBINATION CHEMOTHERAPY; DRUG SUBSTITUTION; ENDOTHELIUM INJURY; FEMALE; FOLLOW UP; GRAND MAL SEIZURE; HEMISPHERE; HUMAN; INTENSIVE CARE; LEUKOENCEPHALOPATHY; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; STUPOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN DISEASES; CECAL NEOPLASMS; CEREBRAL CORTEX; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERTENSIVE ENCEPHALOPATHY; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; REMISSION, SPONTANEOUS;

EID: 33847743454     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098706     Document Type: Article

References (8)

1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR: A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
2. Lamy C, Oppenheim C, Méder JF, Mas JL: Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 2004;14:89-96.
3. Edwards MJJ, Walker R, Vinnicombe S, Barlow C, MacCallum P, Foran JM: Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma. Ann Oncol 2001;12:1327-1329.
4. Gimenez-Mesa E, Martinez-Salio A, Porta-Etessam J, Berbel Garcia A, Cedena Romero T, Salama Bendoyan P: Reversible posterior leukoencephalopathy in a patient with non-Hodgkin's lymphoma after treatment with CHOP. An Med Interna 2001;18:591-593.
5. Stott VL, Hurrell MA, Anderson TJ: Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Intern Med J 2005;35:83-90.
6. Tam CS, Galanos J, Seymour JF, Pitman AG, Stark RJ, Prince HM: Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies. Am J Hematol 2004;77:72-76.
7. Dropcho EJ: Neurotoxicity of cancer chemotherapy. Semin Neurol 2004;24:419-426.
8. Voltz R, Graus F: Diagnosis and treatment of paraneoplastic neurological disorders. Onkologie 2004;27:253-258